Mark E. McDonnell

787 citations

31 papers · 509 indexed · h-index 14

Impact in

Sensory Systems top 10%
- Ion Channels and Receptors
Pharmacology
- Cannabis and Cannabinoid Research

Papers in ⓘ

Sensory Systems 6
- Ion Channels and Receptors 6
Cellular and Molecular Neuroscience 8
- Neuropeptides and Animal Physiology 3

Co-authors: Allen B. Reitz (15 shared papers)Joel Cassel (3 shared papers)Scott L. Dax (5 shared papers)Adrienne E. Dubin (5 shared papers)Venkata Velvadapu (4 shared papers)Garry R. Smith (3 shared papers)Ellen E. Codd (7 shared papers)William A. Kinney (4 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Journal of Medicinal Chemistry (5 papers)Tetrahedron Letters (3 papers)Journal of Molecular Neuroscience (2 papers)Bioorganic & Medicinal Chemistry (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Mark E. McDonnell

30 papers receiving 496 citations

Peers

Countries citing papers authored by Mark E. McDonnell

Since Specialization

Citations

This map shows the geographic impact of Mark E. McDonnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. McDonnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. McDonnell more than expected).

Fields of papers citing papers by Mark E. McDonnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. McDonnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. McDonnell. The network helps show where Mark E. McDonnell may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark E. McDonnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark E. McDonnell Line = papers co-authored together Mark E. McDonnell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth Science Translational Medicine ·Troy E. Messick, Garry R. Smith, Samantha S. Soldan, Mark E. McDonnell, Julianna S. Deakyne, Kimberly A. Malecka, Lois Tolvinski, A. Pieter J. van den Heuvel, Bai-Wei Gu, Joel Cassel, Donna H. Tran, Benjamin R. Wassermann, Yan Zhang, Venkata Velvadapu, Edward R. Zartler, Pierre Busson, Allen B. Reitz, Paul M. Lieberman	2019	88
2	Discovery of KLS-13019, a Cannabidiol-Derived Neuroprotective Agent, with Improved Potency, Safety, and Permeability ACS Medicinal Chemistry Letters ·William A. Kinney, Mark E. McDonnell, Hua Zhong, Chaomin Liu, Lanyi Yang, Wei Ling, Qian Tao, Yu Chen, Zhijie Cai, Dean Petkanas, Douglas E. Brenneman	2016	42
3	Synthesis and in vitro evaluation of a novel iodinated resiniferatoxin derivative that is an agonist at the human vanilloid VR1 receptor Bioorganic & Medicinal Chemistry Letters ·Mark E. McDonnell, Sui-Po Zhang, Adrienne E. Dubin, Scott L. Dax	2002	36
4	Design and Synthesis of Thrombin Inhibitors: Analogues of MD-805 with Reduced Stereogenicity and Improved Potency Journal of Medicinal Chemistry ·Derek E. Brundish, Alice Bull, Vera Donovan, Joseph D. Fullerton, Sheila Garman, Judy Hayler, Diana Janus, Peter D. Kane, Mark E. McDonnell, Garrick P. Smith, Robert Wakeford, Clive V Walker, Graham A. Howarth, William Hoyle, Mark C. Allen, John Ambler, Keith Butler, Mark Talbot	1999	28
5	Orally Active Benzamide Antipsychotic Agents with Affinity for Dopamine D₂, Serotonin 5-HT_1A, and Adrenergic α₁Receptors Journal of Medicinal Chemistry ·Allen B. Reitz, Ellen W. Baxter, Ellen E. Codd, Coralie B. Davis, Alfonzo D. Jordan, Bruce E. Maryanoff, Cynthia A. Maryanoff, Mark E. McDonnell, Eugene T. Powell, Michael J. Renzi, Mary R. Schott, Malcolm K. Scott, Richard P. Shank, Jeffry L. Vaught	1998	27
6	Diclofenac potassium liquid-filled soft gelatin capsules for the treatment of postbunionectomy pain Current Medical Research and Opinion ·Stephen E. Daniels, D. Baum, F. J. Clark, Michael Golf, Mark E. McDonnell, S. Boesing	2010	25
7	Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ Bioorganic & Medicinal Chemistry ·Joel Cassel, Sergey O. Ilyin, Mark E. McDonnell, Allen B. Reitz	2012	25
8	Non-NAD-like PARP-1 inhibitors in prostate cancer treatment Biochemical Pharmacology ·Yaroslava Karpova, Chao Wu, Ali Divan, Mark E. McDonnell, Elizabeth Hewlett, Peter Makhov, John Gordon, Min Ye, Allen B. Reitz, Wayne E. Childers, Tomasz Skórski, Vladimir Kolenko, Alexei V. Tulin	2019	24
9	Riluzole prodrugs for melanoma and ALS: Design, synthesis, and in vitro metabolic profiling Bioorganic & Medicinal Chemistry ·Mark E. McDonnell, Matthew D. Vera, Benjamin E. Blass, Jeffrey C. Pelletier, Richard C. King, Carmen Fernández‐Metzler, Garry R. Smith, Jay Wrobel, Suzie Chen, B. Wall, Allen B. Reitz	2012	24
10	Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist Journal of Pharmacology and Experimental Therapeutics ·Naama Levy‐Cooperman, Gail McIntyre, Laura Bonifacio, Mark E. McDonnell, James M. Davenport, Paul S. Covington, Leonard S. Dove, Edward M. Sellers	2016	24
11	Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function Biochimie ·Joel Cassel, Mark E. McDonnell, Venkata Velvadapu, Vyacheslav Andrianov, Allen B. Reitz	2012	23
12	Heteroaryl β-tetralin ureas as novel antagonists of human TRPV1 Bioorganic & Medicinal Chemistry Letters ·Michele C. Jetter, Mark A. Youngman, James J. McNally, Mark E. McDonnell, Sui‐Po Zhang, Adrienne E. Dubin, Nadia Nasser, Ellen E. Codd, Christopher M. Flores, Scott L. Dax	2007	18
13	7-Hydroxynaphthalen-1-yl-urea and -amide antagonists of human vanilloid receptor 1 Bioorganic & Medicinal Chemistry Letters ·Mark E. McDonnell, Sui-Po Zhang, Nadia Nasser, Adrienne E. Dubin, Scott L. Dax	2003	16
14	Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark E. McDonnell, Haiyan Bian, Jay Wrobel, Garry R. Smith, Shuguang Liang, Haiching Ma, Allen B. Reitz	2014	15
15	Cypin: A novel target for traumatic brain injury Neurobiology of Disease ·Przemyslaw Swiatkowski, Emily Sewell, Eric S. Sweet, Samantha Dickson, Rachel Swanson, Sara A. McEwan, Nicholas G. Cuccolo, Mark E. McDonnell, Mihir V. Patel, Nevin Varghese, Barclay Morrison, Allen B. Reitz, David F. Meaney, Bonnie L. Firestein	2018	13
16	The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors Bioorganic & Medicinal Chemistry Letters ·Bin Zhu, Peter J. Connolly, Yuemei Zhang, Mark E. McDonnell, Haiyan Bian, Shu-Chen Lin, Li Liu, Sui‐Po Zhang, Kristen Chevalier, Michael R. Brandt, Cynthia Milligan, Christopher M. Flores, Mark J. Macielag	2020	12
17	The synthesis and evaluation of the major metabolites of mazapertine Bioorganic & Medicinal Chemistry Letters ·Allen B. Reitz, Mark E. McDonnell, Ellen W. Baxter, Ellen E. Codd, Wu‐Nan Wu	1997	11
18	N-Aryl-N'-Benzylpiperazines as Potential Antipsychotic Agents Journal of Medicinal Chemistry ·Allen B. Reitz, Ellen W. Baxer, Debra J. Bennett, Ellen E. Codd, Alfonzo D. Jordan, Elizabeth A. Malloy, Bruce E. Maryanoff, Mark E. McDonnell, Marta E. Ortegón	1995	10
19	Anti-Inflammatory Properties of KLS-13019: a Novel GPR55 Antagonist for Dorsal Root Ganglion and Hippocampal Cultures Journal of Molecular Neuroscience ·Douglas E. Brenneman, William A. Kinney, Mark E. McDonnell, Pingei Zhao, Mary E. Abood, Sara Jane Ward	2022	8
20	Synthesis and Characterization of Novel Ferrocenyl-Substituted Pyrroles Synthetic Communications ·Norman H. Nemeroff, Mark E. McDonnell, Jeffrey M. Axten, Leonard J. Buckley	1992	8

About Mark E. McDonnell

Mark E. McDonnell is a scholar working on Sensory Systems, Cellular and Molecular Neuroscience, Pharmacology, Molecular Biology and Physiology, having authored 31 papers that have together received 509 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (6 papers), Ion Channels and Receptors (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers), Receptor Mechanisms and Signaling (3 papers), Cannabis and Cannabinoid Research (3 papers), Neuropeptides and Animal Physiology (3 papers), Ion channel regulation and function (3 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Sensory Systems (55 citations), Pharmacology (83 citations), Oncology (107 citations), Organic Chemistry (105 citations) and Cellular and Molecular Neuroscience (56 citations). Mark E. McDonnell has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Allen B. Reitz, Joel Cassel, Scott L. Dax, Adrienne E. Dubin, Venkata Velvadapu, Garry R. Smith, Ellen E. Codd, William A. Kinney, Sergey O. Ilyin and Nadia Nasser. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Tetrahedron Letters, Journal of Molecular Neuroscience and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact